Boehringer to cut costs by 15%

Share this article:

Boehringer Ingelheim plans to cut costs by around 15%, which means layoffs. PMLive found the pink-slip item in the German paper Frankfurter Allgemeine Zeitung. The news comes one day after the firm announced disappointing financials for the first half of the year—prescription sales slid 5.4%, to $6.4 billion. The company attributed part of the falloff to deeper discounts required to fit into the post-healthcare-reform marketplace in the US.

PMLive says it is unclear if the layoffs will be distributed throughout the global 45,000-employee workforce or limited to Germany.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.